I started internal medicine residency 1,5 months ago and this short period was short enough to change my perspective. During medical school, I was enjoying being a part of wet lab and clinical studies however, I didn’t have much purpose. I was simply enjoying it. Of course, I saw that we need to do better as clinicians and scientists but I wasn’t feeling that to my core. As I began to become the primary physician of patients I saw that we are failing. We are failing greatly!
I was writing the overall survival of glioblastoma is around 14 months and new therapy approaches are needed in the introduction of our article on glioblastoma. I have been following a glioblastoma patient in our inpatient clinic for the last couple of weeks and now I understand what 14 months mean to a patient and their relatives. And now I truly understand why we need to do better.
Recently, a study I contributed to was published and I loved that it might have clinical implications. Now I am very happy to share that another study that originated from a clinical question is published now! Dr Binici led the study and it was once again nice to work with this team.
Radiotherapy-induced fibrosis is a major problem for breast reconstructive surgery. In our study, we showed that plasma-rich platelets and infliximab combination could mitigate the adverse effects of radiotherapy.
To read the study: https://link.springer.com/article/10.1007/s00418-024-02267-z
